AstraZeneca chief executive sees changes ahead for DTC
February 01 2005
Speaking at the World Health Care Forum this week, AstraZeneca president and chief executive David Brennan said he anticipates changes ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.